Physician

Christopher G. Fuller, M.D.

According to 2025 Medicare claims, Christopher Fuller, M.D. (NPI: 1790830032) practices ophthalmology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is TEXAS RETINA ASSOCIATES (NPI: 1093750853; TIN: 751362336) and primary practice location at 79424-5013.

Fuller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,290 traditional Medicare patients, billed 97,703 HCPCS/CPT codes, and received $4,928,406 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 762 prescription claims across 317 beneficiaries totaling $83,472 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 70 records totaling $39,592. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $732,200 to $4,928,406. Similarly, Part D prescription costs have risen steadily, from $57,503 to $83,472. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	801	5,981	$732,200
2016	1,022	10,307	$1,544,990
2017	1,100	10,976	$1,886,816
2018	1,063	12,234	$2,229,015
2019	1,161	11,810	$2,515,024
2020	1,037	11,595	$2,476,288
2021	1,120	11,534	$2,516,575
2022	1,154	23,164	$2,663,711
2023	1,254	64,177	$3,625,375
2024	1,290	97,703	$4,928,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	194	544	$57,503
2016	155	374	$40,381
2017	157	384	$55,346
2018	171	353	$47,516
2019	185	438	$68,681
2020	250	666	$60,626
2021	357	924	$75,879
2022	319	851	$68,915
2023	220	543	$104,015
2024	317	762	$83,472

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92004	New patient complete exam of visual system	413	413	$108
67028	Injection of drug into eye	595	2,005	$95
92014	Established patient complete exam of visual system	653	937	$88
92134	Imaging of retina	1,233	3,185	$30
J2777	Injection, faricimab-svoa, 0.1 mg	385	75,439	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xiidra	Lifitegrast	22	780	$17,341
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	241	5,136	$9,843
Prolensa	Bromfenac Sodium	25	746	$8,599
Tobradex St	Tobramycin/Dexamethasone	36	822	$8,403
Vyzulta	Latanoprostene Bunod	14	496	$5,792

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$5,539	Alimera Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$34,053	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher G. Fuller, M.D.?

Tedicare shows public-source Medicare data for Christopher G. Fuller, M.D. (NPI 1790830032), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher G. Fuller, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher G. Fuller, M.D.?

Christopher G. Fuller, M.D. is linked to TEXAS RETINA ASSOCIATES (billing NPI 1093750853) in the available physician profile data.

Does Christopher G. Fuller, M.D. have Open Payments data?

Christopher G. Fuller, M.D. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.